The trademark application Bundisarin was filed by Aristo Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on December 17, 2017, and it was registered by office on March 25, 2018 without any oppositions.
It was designated 'Basic Application' for International Application 1418506 at the World Intellectual Property Organization (WIPO).
The application was filed in Swedish (German was selected as the second language).
International trade mark of the trademark registration was recorded on August 16, 2018.